Varroa Calmodulin dsRNA for Selective Mite Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling Varroa mite infestations in honey bees are ineffective, leading to colony collapse and the introduction of toxic chemicals into honey, with bees developing resistance to existing miticides and no effective preventative measures for Colony Collapse Disorder (CCD).
Innovation Solution
Development of selective insecticide compositions comprising anti-parasitic, anti-pest or insecticidal nucleic acid molecules that are complementary or identical to regions of a Varroa calmodulin gene sequence, specifically designed to target Varroa destructor without affecting non-target organisms, incorporated into bee feeds or delivered through nucleic acid constructs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If chemical miticides are used to control Varroa mite infestations, then mite levels are reduced, but the chemicals become toxic and leave residues in wax and honey
Solution Approach 1:
The patent replaces chemical miticides with a biological control mechanism using double-stranded RNA (dsRNA) that triggers RNA interference (RNAi) in Varroa mites. This molecular-level intervention specifically targets calmodulin gene expression in mites, eliminating the need for toxic chemicals while maintaining control efficacy.
Solution Approach 2:
The patent introduces dsRNA as an intermediary substance that mediates between the beekeeper's control goal and the Varroa mite population. The dsRNA acts as a selective agent that enters mites through feeding, silences essential genes, and causes mortality without affecting honey bees or leaving harmful residues in honey.
2Reliability
If oxalic or formic acid is applied to control Varroa mites, then some mite reduction is achieved, but toxicity to treated colonies increases
Solution Approach 1:
The patent applies local quality by making the control agent (dsRNA) specific to Varroa mites through sequence complementarity to the mite calmodulin gene. The dsRNA only affects organisms with matching genetic sequences, creating a localized effect that spares honey bees and beneficial insects while targeting only the pest population.
3Reliability
If breeding for Varroa resistance is implemented, then some resistance is developed, but practical success is limited
Solution Approach 1:
The patent implements preliminary action by applying dsRNA treatment to honeybee colonies before Varroa mite populations can reach collapse-level infestations. The treatment proactively prevents colony collapse rather than reacting to established infestations, maintaining colony health and productivity while controlling mite populations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nucleic acid molecules effectively reduce Varroa mite infestations and parasite loads in honeybee colonies, potentially preventing Colony Collapse Disorder while minimizing harm to honey bees and ensuring the safety of honey for human consumption.
Implementation Method 1
double-stranded RNA molecules that are complementary to or identical to a region of a Varroa calmodulin gene sequence or an RNA transcribed therefrom
Data Source
AI summary
This application provides and discloses anti-parasitic, anti-pest or insecticidal nucleic acid molecules and their calmodulin target genes for the control of arthropod parasites and pests. In particular, this application provides and discloses insecticidal nucleic acid molecules that target Varroa calmodulin gene sequences. This application further provides methods and compositions for the control and treatment of parasites and pests in Apis mellifera (honey bee) hives.